PWM
AZN icon

PRW Wealth Management’s AstraZeneca AZN Stock Holding History

PRW Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-28,071
Closed -$3.36M – 108
2021
Q2 		$3.36M Buy
+28,071
New +$3.08M 0.99% 16

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PRW Wealth Management's AZN Position: Q3 2021 in Review

PRW Wealth Management sold out of AstraZeneca (AZN) in Q3 2021, closing a stake of 28,071 shares — an estimated $3.36M sold.

PRW Wealth Management first reported a position in AZN in Q2 2021 and held it in 1 quarter. The position peaked at $3.36M in Q2 2021. 908 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

  • PRW Wealth Management reported no remaining AstraZeneca position as of Q3 2021 after selling out during the quarter.
  • PRW Wealth Management sold 28,071 AstraZeneca shares in Q3 2021, an estimated $3.36M.
  • PRW Wealth Management first reported a position in AstraZeneca in Q2 2021 and held it in 1 quarter.
  • PRW Wealth Management's AstraZeneca position peaked at $3.36M in Q2 2021.
  • 908 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on PRW Wealth Management's 13F filing for Q3 2021, filed 4 Nov 2021.